Viewing Study NCT02718066


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-24 @ 8:05 PM
Study NCT ID: NCT02718066
Status: COMPLETED
Last Update Posted: 2023-11-09
First Post: 2016-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Sponsor: HUYABIO International, LLC.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: HBI-8000-302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators